版本:
中国

BRIEF-Neos Therapeutics reports Q4 loss per share of $1.14

March 14 Neos Therapeutics Inc

* Reports fourth quarter and full year 2016 financial results

* Qtrly net product sales $3.5 million versus $1.7 million

* Qtrly loss per share $1.14

* As of December 31, 2016, company's cash, cash equivalents and short-term investments amounted to $39.8 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐